Carbon Nanotubes as Drug Delivery Vehicles

Abstract:

Various biomedical applications of nanomaterials have been proposed in the last few years leading to the emergence of a new field in diagnostics and therapeutics. Most of these applications involve the administration of nanoparticles into patients. Carbon Nanotubes are enjoying increasing popularity as building blocks for novel drug delivery systems as well as for bioimaging and biosensing. The recent strategies to functionalize carbon nanotubes have resulted in the generation of biocompatible and water-soluble carbon nanotubes that are well suited for high treatment efficacy and minimum side effects for future cancer therapies with low drug doses. The toxicological profile of such carbon nanotube systems developed as nanomedicines will have to be determined prior to any clinical studies undertaken.

• Periodical: Solid State Phenomena (Volume 222)
• Pages: 145-158
• DOI: https://doi.org/10.4028/www.scientific.net/SSP.222.145
• Online since: November 2014
• Authors: Shweta Arora, Vanish Kumar, Shriniwas Yadav, Sukhbir Singh, Deepika Bhatnagar, Inderpreet Kaur*
• Keywords: Biomedical, Cancer, Carbon Nanotube (CN), Drug Delivery, Nanomaterials, Toxicity

References

[1] D. Hanahan, R.A. Weinberg, The Hallmarks of Cancer, Cell 100 (2000) 57-70.

[2] A. Kamb, S. Wee, C. Lengauer, Why is cancer drug discovery so difficult?, Nat. Rev. Drug Discov. 6 (2007) 115-120.

DOI: 10.1038/nrd2155

[3] A.F. Chambers, A.C. Groom, I.C. MacDonald, Dissemination and growth of cancer cells in metastatic sites, Nat. Rev. Cancer 2 (2002) 563-572.

DOI: 10.1038/nrc865

[4] D.K. Chang, C.T. Lin, C.H. Wu, H.C. Wu, A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer, PLOS ONE 4 (2009) 1-11.

DOI: 10.1371/journal.pone.0004171

[5] D.S. Tan, M. Gerlinger, B.T. Teh, C. Swanton, Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference, Eur. J. Cancer 46 (2010) 2166-2177.

DOI: 10.1016/j.ejca.2010.03.019

[6] A. Persidis, Cancer multidrug resistance, Nature Biotechnology 17 (1999) 94-95.

[7] N.W. Shi Kam, H. Dai, Carbon nanotubes as intracellular protein transporters: Generality and biological functionality, J. Am. Chem. Soc. 127 (2005) 6021-6026.

DOI: 10.1021/ja050062v

[8] C.R. Martin, P. Kohli, The emerging field of nanotube biotechnology, Nature Rev. Drug Discov. 2 (2003) 29–37.

DOI: 10.1038/nrd988

[9] K. Kostarelos, The long and short of carbon nanotube toxicity, Nature Biotechnology 26 (2008)774-776.

DOI: 10.1038/nbt0708-774

[10] K.W. Powers, M. Palazuelos, B.M. Moudgil, S.M. Roberts, Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies, Nanotoxicology 1 (2007) 42-51.

DOI: 10.1080/17435390701314902

[11] W. Wu, S. Wieckowski, G. Pastorin, M. Benincasa, C. Klumpp, J.P. Briand, R. Gennaro, M. Prato, A. Bianco, Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes, Angew. Chem. Int. Ed. 44 (2005) 6358-6362.

DOI: 10.1002/anie.200501613

[12] Y. Li, X. Zhang, J. Lu, W. Huang, J. Cheng, Z. Luo, T. Li, F. Liu et. al. Purification of CVD synthesized single-wall carbon nanotubes by different acid oxidation treatments, Nanotechnology 15 (2004) 1645-1649.

DOI: 10.1088/0957-4484/15/11/047

[13] C. Samorì, H. AliBoucetta, R. Sainz, C. Guo, M.F. Toma, C. Fabbro, T. da Ros, M. Prato, K. Kostarelos, A. Bianco, Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers, Chem. Commun. 46 (2010).

DOI: 10.1039/b923560d

[14] C. Tripisciano, E.B. Palen, Cisplatin functionalized single-walled carbon nanotubes, Physica Status Solidi 245 (2008) 1979–(1982).

DOI: 10.1002/pssb.200879558

[15] C.L. Lay, H.Q. Liu, H.R. Tan, Y. Liu, Delivery of paclitaxel by physically loading onto poly- ethylene-glycol-graft carbon nanotubes for potent cancer therapeutics, Nanotechnology 21 (2010) 065101.

DOI: 10.1088/0957-4484/21/6/065101

[16] W. Wu, R. Li, X. Bian, Z. Zhu, D. Ding, X. Li, Z. Jia, X. Jiang, Y. Hu, Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity, ACS Nano 3 (2009) 2740-2750.

DOI: 10.1021/nn9005686

[17] X. Liu, R. H. Hurt, A. B. Kane, Biodurability of single-walled carbon nanotubes depends on surface functionalization, Carbon 48 (2010) 1961-(1969).

DOI: 10.1016/j.carbon.2010.02.002

[18] Y.J. Gu, J. Cheng, J. Jin, S.H. Cheng, W.T. Wong, Development and evaluation of pH-responsive single-walled carbon nanotube-doxorubicin complexes in cancer cells, Int. J. Nanomedicine 6 (2011) 2889–2898.

DOI: 10.2147/ijn.s25162

[19] S. Arora, R. Saharan, H. Kaur, I. Kaur, P. Bubber, L.M. Bharadwaj, Attachment of Docetaxel to Multiwalled Carbon Nanotubes for Drug Delivery Applications, Adv. Sci. Lett. 5 (2012) 1–6.

DOI: 10.1166/asl.2012.4251

[20] M. Prato, K. Kostarelos, A. Bianco, Functionalized carbon nanotubes in drug design and discovery, Acc. Chem. Res. 41 (2007) 60-68.

DOI: 10.1021/ar700089b

[21] G. Pastorin, Crucial Functionalizations of Carbon Nanotubes for Improved Drug Delivery: A Valuable Option? Pharm. Res. 26 (2009) 746-769.

DOI: 10.1007/s11095-008-9811-0

[22] J. Meng, J. Duan, H. Kong, L. Li, C. Wang, S. Xie, S. Chen, N. Gu, H. Xu, X.D. Yang, Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy, Small 4 (2008) 1364–1370.

DOI: 10.1002/smll.200701059

[23] N.W.S. Kam, M. O'Connell, J.A. Wisdom, H. Dai, Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction, Proceedings of the National Academy of Sciences of the United States of America, 102 (2005).

DOI: 10.1073/pnas.0502680102

[24] Y. Seow, M.J. Wood, Biological Gene Delivery Vehicles: Beyond Viral Vectors, Mol. Ther. 17 (2009) 767–777.

DOI: 10.1038/mt.2009.41

[25] Z. R. Yang, H. F. Wang, J. Zhao, Y. Y. Peng, J. Wang, B. A. Guinn, L. Q. Huang, Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy, Cancer Gene Ther. 14 (2007) 599–615.

DOI: 10.1038/sj.cgt.7701054

[26] Z. Liu, M. Winters, M. Holodniy, H. Dai, siRNA Delivery into Human T Cells and Primary Cells with Carbon-Nanotube Transporters, Angew. Chem. Int. Ed. Engl. 46 (2007) 2023–(2027).

DOI: 10.1002/anie.200604295

[27] N.W. Shi Kam, Z. Liu, H. J. Dai Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway, Angew. Chem. Int. Ed. Engl. 45 (2006) 577–581.

DOI: 10.1002/anie.200503389

[28] K. Cho, X. Wang, S. Nie, Z.G. Chen, D.M. Shin, Therapeutic Nanoparticles for Drug Delivery in Cancer, Clin. Cancer Research 14 (2008) 1310-1316.

DOI: 10.1158/1078-0432.ccr-07-1441

[29] D. Cai, J.M. Mataraza, Z.H. Qin, Z. Huang, J. Huang, T.C. Chiles, D. Carnahan, K. Kempa, Z. Ren, Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing, Nature Methods 2 (2005) 449-454.

DOI: 10.1038/nmeth761

[30] M. Adeli, R. Soleyman, Z. Beiranvand, F. Madani, Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube–polymer interactions, Chem. Soc. Rev. 42 (2013) 5231-5256.

DOI: 10.1039/c3cs35431h

[31] K. Kostarelos, Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science, Adv. Colloid Interface Sci. 106 (2003) 147–168.

DOI: 10.1016/s0001-8686(03)00109-x

[32] S. Vardharajula, Sk Z. Ali, P. M. Tiwari, E. Eroğlu, K. Vig, V. A. Dennis, S. R. Singh, Functionalized carbon nanotubes: biomedical applications, International journal of nanomedicine 7 (2012) 5361-5374.

DOI: 10.2147/ijn.s35832

[33] K. Soto, K. M. Garza, L. E. Murr, Cytotoxic effects of aggregated nanomaterials, Acta Biomater. 3 (2007) 351–358.

DOI: 10.1016/j.actbio.2006.11.004

[34] K. Pulskamp, S. Diabateand, H.F. Krug, Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants, Toxicol. Lett. 168 (2007) 58–74.

DOI: 10.1016/j.toxlet.2006.11.001

[35] C.M. Sayes, F. Liang, J.L. Hudson, J. Mendez, W. Guo, J.M. Beach, V.C. Moore et al., Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro, Toxicol. Lett. 161 (2006) 135-142.

DOI: 10.1016/j.toxlet.2005.08.011

[36] D. Pantarotto, R. Singh, D. McCarthy, M. Erhardt, J.P. Briand, M. Prato, K. Kostarelos, A. Bianco, Functionalized carbon nanotubes for plasmid DNA gene delivery, Angew. Chem. Int. Ed. Engl. 43 (2004) 5242-5246.

DOI: 10.1002/anie.200460437

[37] F. Tian, D. Cui, H. Schwarz, G.G. Estrada, H. Kobayashi, Cytotoxicity of single-walled carbon nanotubes on human fibroblasts , Toxicol. in-Vitro, 20 (2006) 1202–1212.

DOI: 10.1016/j.tiv.2006.03.008

[38] S. T. Yang, X. Wang, G. Jia, Y. Gu, T. Wang, H. Nie, C. Ge, H. Wang, Y. Liu, Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice, Toxicol. Lett. 181 (2008) 182–189.

DOI: 10.1016/j.toxlet.2008.07.020

[39] V.S. Thakare, M. Das, A.K. Jain, S. Patil, S. Jain, Carbon nanotubes in cancer theragnosis, Nanomedicine 5 (2010) 1277–1301.

DOI: 10.2217/nnm.10.95

[40] S. Li, P. He, J. Dong, Z. Guo, H. Dai, DNA-Directed Self-Assembling of Carbon Nanotubes, J. Am. Chem. Soc. 127 (2005) 14–15.

DOI: 10.1021/ja0446045

[41] S.T. Yang, X. Wang, G. Jia, Y. Gu, T. Wang, H. Nie, C. Ge, H. Wang, Y. Liu, Long term accumulation and low toxicity of single walled carbon nanotubes in intravenously exposed mice, Toxicol. Lett. 181 (2008) 182-189.

DOI: 10.1016/j.toxlet.2008.07.020

[42] Z. Liu, K. Chen, C. Davis, S. Sherlock, Q. Cao, X. Chen, H. Dai, Drug delivery with carbon nanotubes for in vivo cancer treatment, Cancer Res. 68 (2008) 6652-6660.

DOI: 10.1158/0008-5472.can-08-1468

[43] H. Dumortier, S. Lacotte, G. Pastorin, R. Marega, W. Wu, D. Bonifazi, J.P. Briand, M. Prato, S. Muller, A. Bianco, Functionalized carbon nanotubes are non- cytotoxic and preserve the functionality of primary immune cells, Nano Lett. 6 (2006).

DOI: 10.1021/nl068003i

[44] Z. Liu, A.C. Fan, K. Rakhra, S. Sherlock, A. Goodwin, X. Chen, Q. Yang, D. W. Felsher, H. Dai, Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy, Angew. Chem. Int. Ed. Engl. 48 (2009) 7668-7672.

DOI: 10.1002/anie.200902612

[45] B.L. Allen, G.P. Kotchey, Y. Chen, N.V. Yanamala, J. Klein-Seetharaman, V.E. Kagan, A. Star, Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes, J. Am. Chem. Soc. 131 (2009) 17194-17205.

DOI: 10.1021/ja9083623

[46] Y.A. Zhao, B.L. Allen, A. Star, Enzymatic degradation of multiwalled carbon nanotubes, J. Phys. Chem. A 115 (2011) 9536-9544.

DOI: 10.1021/jp112324d

[47] F.M. Freimoser, C.A. Jakob, M. Aebi, U. Tour, The MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide] Assay is a Fast and Reliable Method for Colorimetric Determination of Fungal Cell Densities, Appl. Environ. Microbiol. 65 (1999).

DOI: 10.1128/aem.65.8.3727-3729.1999

[48] S. Arora., R. Kumar., H. Kaur., C. Singh., I. Kaur., S. K. Arora., J. Srivastava., and L.M. Bharadwaj, Translocation and Toxicity of Docetaxel Multi-Walled Carbon Nanotube Conjugates in Mammalian Breast Cancer Cells, J. Biomed. Nanotech. 10 (2014).

DOI: 10.1166/jbn.2014.1875

[49] L. Lacerda, A. Bianco, M. Prato, K. Kostarelos, Carbon nanotubes as nanomedicines: From toxicology to pharmacology, Adv. Drug Deliv. Rev. 58 (2006) 1460–1470.

DOI: 10.1016/j.addr.2006.09.015